Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Molecular and morphological profiles of developing neurons in vitro uncover the cellular dynamics of human neurodevelopment and related disease.

Space Seed Holdings (SSHD) participated in the 69th Japan Society for Aeronautical and Space Sciences Joint Conference, held ...

A gene that turns on very early in embryonic development could be key to the formation of the placenta, which provides the ...

Typically, bone marrow research relies heavily on animal models and oversimplified cell cultures in the laboratory. Now, researchers from the Department of Biomedicine at the University of Basel and ...

Findings expand Telomir-1’s oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic, and aggressive prostate cancer models. MIAMI, FL / ...

Scalable iPSC neuron manufacturing advances neuroscience, improving disease modeling, therapeutic development, and clinical readiness.

When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...

A gene that turns on very early in embryonic development could be key to the formation of the placenta, which provides the ...